Radioactive elements for scientific purposes; radioactive preparations for scientific purposes; chemicals for use in the manufacture of radiopharmaceutical products; chemical products for radioactive labelling

Chemicals for pharmaceutical use; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products; chemicals for radiopharmaceuticals for diagnostic uses; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radiopharmaceutical products for diagnostic uses; radioactive pharmaceutical preparations; radioactive elements, isotopes, preparations and reagents for radioactive labelling of pharmaceutical products; radiopharmaceuticals

Apparatus for administering pharmaceuticals; apparatus for medical purposes; apparatus for the treatment of cancer; diagnostic imaging apparatus for medical use; pharmaceutical instruments; applicators for pharmaceutical preparations; medical apparatus kits for preparing diagnostic imaging agents; medical apparatus for administering radiopharmaceutical diagnostic products

Advertising; business advisory services relating to product development; business consultancy; retail or wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies; intermediary business services relating to the commercialisation of goods

Manufacture of radiopharmaceutical products (term considered too vague by the International Bureau -rule 13 (2) (b) of the Regulations); radiolabelling of pharmaceutical products (term considered too vague by the International Bureau -rule 13 (2) (b) of the Regulations)

Provision of scientific information; scientific and technical analysis; scientific consultancy; scientific research; scientific research in the field of pharmacy; medical research; research and development of products; research relating to pharmaceuticals; advisory services relating to immunological products; development of new techniques for radiolabelling of pharmaceutical products

Exploitation of intellectual property rights (term considered too vague by the International Bureau -rule 13 (2) (b) of the Regulations); licensing of intellectual property